Open access · CC-BY
via OpenAlex
Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin
IntechOpen eBooks · 2019 · ▲ 4 citations
Deregulated nutrient-sensing
Chronic inflammation
Disabled macroautophagy
Caloric restriction
Rapamycin / mTOR inhibition
Metformin
Yeast
C. elegans
Human
Mouse
Abstract
The molecular mechanisms underlying the quality and quantity of life extension appear to sometimes be orthogonal. For example, while resveratrol has continued to prove beneficial in reducing obesity, it has had less efficacy in extending lifespan. On the other hand, mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) and the chemically similar rapalogs extend lifespan across genera of life from yeast, to nematodes, to mice. Caloric restriction(definition) (CR) and bioavailable small molecules, which mimic a fasted state, upregulate autophagy(definition), catabolism of fats over anabolism of carbohydrates, and decrease oxidative stress and inflammation. CR mimics are currently being investigated to elucidate the best dosage, route of administration, timing in life, where best to inhibit in the mTOR pathway, and effects of long-term use on mTORC1 verse mTORC2 complexes. Comparisons between rapamycin, resveratrol, and metformin targets, downstream pathway effects, dosage, and clinical trials will be discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5772/intechopen.79338
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Arbor, S. (2019). Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin. <em>IntechOpen eBooks</em>. https://doi.org/10.5772/intechopen.79338
Vancouver
Arbor S. Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin. IntechOpen eBooks. 2019. doi:10.5772/intechopen.79338.
BibTeX
@article{sage2019Wherea,
title = {Where and How in the mTOR Pathway Inhibitors Fight Aging: Rapamycin, Resveratrol, and Metformin},
author = {Sage Arbor},
journal = {IntechOpen eBooks},
year = {2019},
doi = {10.5772/intechopen.79338},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Innovation in Aging 2019
Open access · CC-BY
TARGETING THE MTOR NETWORK TO MAXIMIZE HEALTHSPAN
AGE 2013
Open access · OA
Contrasting effects of chronic, systemic treatment with mTOR inhibitors rapamycin and metformin on adult neural progenitors in mice
Innovation in Aging 2025
Open access · CC-BY
Testing the Translational Potential of Rapamycin on Healthy Aging
Genes 2026
Open access · OA
Epigenetic Skeletal Muscle Memory: The Impact of Physical Activity on Aging and Post-Injury Regeneration.
iScience 2022
Open access · CC-BY
Usnic Acid extends healthspan and improves the neurodegeneration diseases via mTOR/PHA-4 signaling pathway in Caenorhabditis elegans
Journal of Biosafety & Health Education 2013
Open access · OA